secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corvus Pharmaceuticals, Inc. (CRVS)
CIK:        0001626971
Form:       8-K
Filed at:   2023-03-13T23:59:59+00:00
Accession:  0001171843-23-001602
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Corvus Pharmaceuticals confirms no cash or securities at Silicon Valley Bank
----------------------------------------------------------------------------

- Corvus Pharmaceuticals, on March 10, 2023, stated it does not hold cash deposits or securities at Silicon Valley Bank.
- The disclosure addresses investor concerns after Silicon Valley Bank's collapse.
- Company's liquidity unaffected by SVB failure; no cash or securities at risk.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1626971/000117184323001602/0001171843-23-001602-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1626971/000117184323001602/f8k_031023.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-001602

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer